Foscarbidopa is a synthetic derivative of L-tyrosine and a water-soluble prodrug of carbidopa, used in the treatment of Parkinson's disease. It is under investigation as a component of continuous subcutaneous infusion for managing motor fluctuations in Parkinson's disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Foscarbidopa?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
MAGNESIUM HYDROXIDE
Compound for research and industrial applications
1,6-Dibromonaphthalene
Chemical intermediate for research and manufacturing
(4-Nitrophenyl)methyl 2-(3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-methylbut-2-enoate
Not specified
(S)-1-(1H-Benzimidazol-2-yl)ethanol
Research compound
The international HS code for Foscarbidopa (CAS 1907685-81-7) is 2928.00.
2928.00
2928 00 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-2-hydrazinyl-3-(3-hydroxy-4-phosphonooxyphenyl)-2-methylpropanoic acid
PQUZXFMHVSMUNG-JTQLQIEISA-N
C[C@](CC1=CC(=C(C=C1)OP(=O)(O)O)O)(C(=O)O)NN
Sourcing Foscarbidopa?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.